Log in

Seres Therapeutics Earnings Date, Estimates & History (NASDAQ:MCRB)

$3.22
+0.09 (+2.88 %)
(As of 01/28/2020 03:43 AM ET)
Today's Range
$2.93
Now: $3.22
$3.25
50-Day Range
$2.87
MA: $3.65
$4.41
52-Week Range
$2.02
Now: $3.22
$8.39
Volume170,000 shs
Average Volume250,447 shs
Market Capitalization$225.44 million
P/E RatioN/A
Dividend YieldN/A
Beta1.78

Earnings

Seres Therapeutics (NASDAQ:MCRB) Earnings Information

Seres Therapeutics last released its quarterly earnings results on November 5th, 2019. The biotechnology company reported ($0.23) earnings per share for the quarter, beating the consensus estimate of ($0.26) by $0.03. The firm had revenue of $7.03 million for the quarter, compared to the consensus estimate of $6.69 million. Seres Therapeutics has generated ($2.43) earnings per share over the last year. Seres Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, March 4th, 2020 based off prior year's report dates.

Seres Therapeutics Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Seres Therapeutics (NASDAQ:MCRB) Earnings Estimates

2020 EPS Consensus Estimate: ($0.83)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20201($0.21)($0.21)($0.21)
Q2 20201($0.22)($0.22)($0.22)
Q3 20201($0.19)($0.19)($0.19)
Q4 20201($0.21)($0.21)($0.21)

Seres Therapeutics (NASDAQ MCRB) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSGAAP EPSRevenue EstimateActual RevenueConference CallDetails
3/4/2020
(Estimated)
       
11/5/2019Q3($0.26)($0.23)($0.23)$6.69 million$7.03 millionTranscript
8/6/2019Q2($0.41)($0.24)($0.24)$10.29 million$12.53 millionN/A
5/2/20193/31/2019($0.43)($0.55)($0.51)$8.61 million$7.32 millionTranscript
3/6/201912/31/2018($0.67)($0.52)($0.52)$3.78 million$10.63 millionTranscript
11/8/2018Q3($0.57)($0.54)($0.54)$23.43 million$9.06 millionN/A
8/2/2018Q2 2018($0.69)($0.68)($0.68)$5.22 million$4.61 millionN/A
5/9/2018Q1 2018($0.75)($0.69)($0.69)$3.00 million$3.97 millionN/A
3/8/2018Q4 2017($0.73)($0.71)($0.71)$3.00 million$3.06 millionTranscript
11/8/2017Q3 2017($0.39)($0.17)($0.17)$17.29 million$23.00 millionN/A
8/3/2017Q2 2017($0.59)($0.69)($0.69)$3.00 million$3.00 millionListen
5/4/2017Q1 2017($0.65)($0.63)($0.63)$3.00 million$3.02 millionListen
3/16/2017Q4 2016($0.70)($0.6260)($0.63)$3.00 million$3.00 millionN/A
11/10/2016Q316($0.55)($0.46)($0.46)$10.38 million$13.02 millionListen
8/11/2016Q216($0.46)($0.70)($0.70)$4.20 million$3.00 millionListen
5/16/2016Q116($0.48)($0.50)($0.50)$1.25 million$2.71 millionListen
2/25/2016Q4 2015($0.40)($0.41)($0.41)N/A
11/10/2015Q315($0.32)($0.38)($0.38)Listen
8/6/2015Q215($0.30)($1.45)N/A
(Earnings results data provided by Zacks Investment Research)
This page was last updated on 1/28/2020 by MarketBeat.com Staff

Featured Article: Stock Symbol

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel